Tick-borne diseases (TBDs) occur worldwide, and historically, only certain pockets of the United States posed a risk for such infections. However, the geographic range of ticks has expanded in North America, leading to a higher risk of exposure to TBDs for the general public. Additionally, a number of emerging and novel pathogens transmitted by ticks have recently been identified in the United States, including Borrelia miyamotoi, Borrelia mayonii, and Ehrlichia muris subsp. eauclairensis. Due to the increased risk of exposure and the increased number of potential tick-borne pathogens, it is increasingly important that physicians recognize who to test, when to test, and what test to use for patients presenting with symptoms of a TBD. We offer a full menu of individual tests and panels that aid in the diagnosis of TBDs. In addition to our comprehensive testing menu, we have developed an algorithmic approach to TBD testing to help guide and optimize testing.
Tick-Borne Diseases Testing at Mayo Clinic
Distribution of Tick-Borne Diseases in the United States, 2016
(Interactive Feature Coming Soon)
How to OrderMany hospitals across the country have already established an account with Mayo Medical Laboratories. Please click on the links below to register for an account, sign in, or request that an MML representative contact you to discuss your current account status and ordering options.